- Home
- APRE vs NUCLW Comparison
APRE vs NUCLW Comparison
Compare APRE & NUCLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.84
N/A
Current Price
$1.54
Company Overview
Basic Information| Metric | APRE | NUCLW |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3M | 7.4M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | APRE | NUCLW |
|---|---|---|
| Price | $0.84 | $1.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 252.0K | 187.4K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $0.82 |
| 52 Week High | $2.76 | $1.39 |
Technical Indicators
Market Signals| Indicator | APRE | NUCLW |
|---|---|---|
| Relative Strength Index (RSI) | 52.68 | 72.58 |
| Support Level | $0.55 | N/A |
| Resistance Level | $1.02 | N/A |
| Average True Range (ATR) | 0.09 | 0.22 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 59.42 | 87.65 |
Price Performance
Historical Comparison APRE
NUCLW
About APRE Aprea Therapeutics Inc.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.